Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
Big Pharmas tell Fierce's London event about their ideal biotech
Dealmakers for five of the biggest pharmas shared the stage at Fierce's event in London to debate what they look for in a dream biotech partner.
Ben Adams
Nov 18, 2026 5:18am
Merck axes $2.7B BTK inhibitor program after seeing ph. 3 data
Nov 18, 2026 3:11am
Merck’s MASH hopeful efinopegdutide wins in mid-stage study
Nov 9, 2026 3:33pm
Merck ends Sutro-partnered IL-2 drug in ‘routine prioritization’
Nov 6, 2026 4:20am
From RAS rivalry to leaked readouts, ESMO brought the data drama
Oct 27, 2026 8:00am
ESMO: Merck exec unruffled by ‘unfortunate’ cancer vax data leak
Oct 24, 2026 6:24am